SOX7: From a developmental regulator to an emerging tumor suppressor

Histology and Histopathology

Volumn 29, Issue 4, 2014, Pages 439-445

  Stovall, Daniel B ^a   Cao, Paul ^b   Sui, Guangchao ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Gene expression; SOX7; Transcription factor; Tumor suppressor

Indexed keywords

SOX7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; SOXF TRANSCRIPTION FACTORS;

EID: 84897075144     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Anbazhagan R., Fujii H. and Gabrielson E. (1998). Allelic loss of chromosomal arm 8p in breast cancer progression. Am. J. Pathol. 152, 815-819.
2. Beck K., Hunter I. and Engel J. (1990). Structure and function of laminin: Anatomy of a multidomain glycoprotein. FASEB J. 4, 148-160.
3. Bernard P. and Harley V.R. (2010). Acquisition of sox transcription factor specificity through protein-protein interaction, modulation of wnt signalling and post-translational modification. Int. J. Biochem. Cell Biol. 42, 400-410.
4. Castillo S.D. and Sanchez-Cespedes M. (2012). The sox family of genes in cancer development: Biological relevance and opportunities for therapy. Expert Opin. Ther. Targets 16, 903-919.
5. Chan D.W., Mak C.S., Leung T.H., Chan K.K. and Ngan H.Y. (2012). Down-regulation of sox7 is associated with aberrant activation of wnt/b-catenin signaling in endometrial cancer. Oncotarget 3, 1546-1556.
6. Chung M.I., Ma A.C., Fung T.K. and Leung A.Y. (2011). Characterization of sry-related hmg box group f genes in zebrafish hematopoiesis. Exp. Hematol. 39, 986-998.
7. Costa G., Mazan A., Gandillet A., Pearson S., Lacaud G. and Kouskoff V. (2012). Sox7 regulates the expression of ve-cadherin in the haemogenic endothelium at the onset of haematopoietic development. Development 139, 1587-1598.
8. Dickson C., Smith R., Brookes S. and Peters G. (1984). Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2. Cell 37, 529-536.
9. DiNapoli L. and Capel B. (2008). Sry and the standoff in sex determination. Mol. Endocrinol. 22, 1-9.
10. Engel J. (1992). Laminins and other strange proteins. Biochemistry 31, 10643-10651.
11. Esser S., Lampugnani M.G., Corada M., Dejana E. and Risau W. (1998). Vascular endothelial growth factor induces ve-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111 (Pt 13), 1853-1865.
12. Fan R., Zhang L.Y., Wang H., Yang B., Han T., Zhao X.L., Wang W., Wang X.Q. and Lin G.W. (2012). Methylation of the cpg island near sox7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome. Tohoku J. Exp. Med. 227, 119-128.
13. Francois M., Koopman P. and Beltrame M. (2010). Soxf genes: Key players in the development of the cardio-vascular system. Int. J. Biochem. Cell Biol. 42, 445-448.
14. Futaki S., Hayashi Y., Emoto T., Weber C.N. and Sekiguchi K. (2004). Sox7 plays crucial roles in parietal endoderm differentiation in f9 embryonal carcinoma cells through regulating gata-4 and gata-6 expression. Mol. Cell Biol.24, 10492-10503.
15. Gandillet A., Serrano A.G., Pearson S., Lie A.L.M., Lacaud G. and Kouskoff V. (2009). Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood 114, 4813-4822.
16. Guo L., Zhong D., Lau S., Liu X., Dong X.Y., Sun X., Yang V.W., Vertino P.M., Moreno C.S., Varma V., Dong J.T. and Zhou W. (2008). Sox7 is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol. Cancer Res. 6, 1421-1430.
17. Hanahan D. and Weinberg R.A. (2011). Hallmarks of cancer: The next generation. Cell 144, 646-674.
18. Harley V.R., Lovell-Badge R. and Goodfellow P.N. (1994). Definition of a consensus DNA binding site for sry. Nucleic Acids Res. 22, 1500-1501.
19. Hayano T., Garg M., Yin D., Sudo M., Kawamata N., Shi S., Chien W., Ding L.W., Leong G., Mori S., Xie D., Tan P. and Koeffler H.P. (2013). Sox7 is down-regulated in lung cancer. J. Exp. Clin. Cancer Res. 32, 17.
20. Herpers R., van de Kamp E., Duckers H.J. and Schulte-Merker S. (2008). Redundant roles for sox7 and sox18 in arteriovenous specification in zebrafish. Circ. Res. 102, 12-15.
21. Katoh M. (2002). Expression of human sox7 in normal tissues and tumors. Int. J. Mol. Med. 9, 363-368.
22. Lefebvre V., Dumitriu B., Penzo-Mendez A., Han Y. and Pallavi B. (2007). Control of cell fate and differentiation by sry-related highmobility-group box (sox) transcription factors. Int. J. Biochem. Cell Biol. 39, 2195-2214.
23. Li B., Ge Z., Song S., Zhang S., Yan H., Huang B. and Zhang Y. (2012). Decreased expression of sox7 is correlated with poor prognosis in lung adenocarcinoma patients. Pathol. Oncol. Res. 18, 1039-1045.
24. Logan C.Y. and Nusse R. (2004). The wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810.
25. Mahmood R., Kiefer P., Guthrie S., Dickson C. and Mason I. (1995). Multiple roles for fgf-3 during cranial neural development in the chicken. Development 121, 1399-1410.
26. McKay I.J., Lewis J. and Lumsden A. (1996). The role of fgf-3 in early inner ear development: An analysis in normal and kreisler mutant mice. Dev. Biol. 174, 370-378.
27. Murakami A., Shen H., Ishida S. and Dickson C. (2004). Sox7 and gata-4 are competitive activators of fgf-3 transcription. J. Biol. Chem. 279, 28564-28573.
28. Niimi T., Hayashi Y., Futaki S. and Sekiguchi K. (2004). Sox7 and sox17 regulate the parietal endoderm-specific enhancer activity of mouse laminin alpha1 gene. J. Biol. Chem. 279, 38055-38061.
29. Saegusa M., Hashimura M. and Kuwata T. (2012). Sox4 functions as a positive regulator of beta-catenin signaling through upregulation of tcf4 during morular differentiation of endometrial carcinomas. Lab. Invest. 92, 511-521.
30. Seguin C.A., Draper J.S., Nagy A. and Rossant J. (2008). Establishment of endoderm progenitors by sox transcription factor expression in human embryonic stem cells. Cell Stem Cell 3, 182-195.
31. Siino J.S., Nissen M.S. and Reeves R. (1995). Replacement of conserved threonines by alanine residues in high mobility group protein hmg-i(y): Effect on DNA binding affinity. Biochem. Biophys. Res. Commun. 207, 497-507.
32. Sinclair A.H., Berta P., Palmer M.S., Hawkins J.R., Griffiths B.L., Smith M.J., Foster J.W., Frischauf A.M., Lovell-Badge R. and Goodfellow P.N. (1990). A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346, 240-244.
33. Sinner D., Kordich J.J., Spence J.R., Opoka R., Rankin S., Lin S.C., Jonatan D., Zorn A.M. and Wells J.M. (2007). Sox17 and sox4 differentially regulate beta-catenin/t-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell Biol. 27, 7802-7815.
34. Stovall D.B., Wan M., Miller L.D., Cao P., Maglic D., Zhang Q., Stampfer M.R., Liu W., Xu J. and Sui G. (2013). The regulation of sox7 and its tumor suppressive role in breast cancer. Am. J. Pathol. 183, 1645-1653.
35. Stros M., Launholt D. and Grasser K.D. (2007). The hmg-box: A versatile protein domain occurring in a wide variety of DNA-binding proteins. Cell. Mol. Life Sci. 64, 2590-2606.
36. Suva M.L., Riggi N. and Bernstein B.E. (2013). Epigenetic reprogramming in cancer. Science 339, 1567-1570.
37. Takash W., Canizares J., Bonneaud N., Poulat F., Mattei M.G., Jay P. and Berta P. (2001). Sox7 transcription factor: Sequence, chromosomal localisation, expression, transactivation and interference with wnt signalling. Nucleic Acids Res. 29, 4274-4283.
38. Timpl R. and Brown J.C. (1994). The laminins. Matrix Biol. 14, 275-281.
39. Vervoort S.J., van Boxtel R. and Coffer P.J. (2012). The role of sryrelated hmg box transcription factor 4 (sox4) in tumorigenesis and metastasis: Friend or foe? Oncogene. 32, 3397-3409.
40. Vestweber D. (2008). Ve-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler. Thromb. Vasc. Biol. 28, 223-232.
41. Wat M.J., Beck T.F., Hernandez-Garcia A., Yu Z., Veenma D., Garcia M., Holder A.M., Wat J.J., Chen Y., Mohila C.A., Lally K.P., Dickinson M., Tibboel D., de Klein A., Lee B. and Scott D.A. (2012). Mouse model reveals the role of sox7 in the development of congenital diaphragmatic hernia associated with recurrent deletions of 8p23.1. Hum. Mol. Genet. 21, 4115-4125.
42. Wilkinson D.G., Bhatt S. and McMahon A.P. (1989). Expression pattern of the fgf-related proto-oncogene int-2 suggests multiple roles in fetal development. Development 105, 131-136.
43. Zhang C., Basta T. and Klymkowsky M.W. (2005). Sox7 and sox18 are essential for cardiogenesis in xenopus. Dev. Dyn. 234, 878-891.
44. Zhang Y., Huang S., Dong W., Li L., Feng Y., Pan L., Han Z., Wang X., Ren G., Su D., Huang B. and Lu J. (2009). Sox7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett. 277, 29-37.
45. Zhong W.D., Qin G.Q., Dai Q.S., Han Z.D., Chen S.M., Ling X.H., Fu X., Cai C., Chen J.H., Chen X.B., Lin Z.Y., Deng Y.H., Wu S.L., He H.C. and Wu C.L. (2012). Soxs in human prostate cancer: Implication as progression and prognosis factors. BMC Cancer 12, 248.
46. Zhou X., Huang S.Y., Feng J.X., Gao Y.Y., Zhao L., Lu J., Huang B.Q. and Zhang Y. (2011). Sox7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells. World J. Gastroenterol. 17, 4922-4927.